Skip to main content
Top
Published in: Clinical Rheumatology 6/2019

01-06-2019 | Pain Syndromes | Letter to the Editor

Elusive trochanteric bursitis relief

Author: Bruce Rothschild

Published in: Clinical Rheumatology | Issue 6/2019

Login to get access

Excerpt

An interesting observation draws attention to technique issues. Nissen et al. [1] found that intra-trochanteric injection with betamethasone produced no greater long-term benefit than saline injections for greater trochanteric pain syndrome. One, three, and six month post-injection pain intensity was unaffected by this intervention. Their recommendation that future patients be advised of unlikely long-term benefit would seem reasonable, except for two fundamental methodologic flaws precluding such clinical application of their findings. Betamethasone is water soluble [2] and the terminology trochanteric bursa may be misleading. There are actually four bursa surrounding attachments to the femoral greater trochanter [3]. Those have been variously reported to include the gluteus medius, gluteus minimus, subgluteus medius, and subgluteus minimus tendons [3, 4]. …
Literature
1.
go back to reference Nissen MJ, Brulhart L, Faundez A, Finckh A, Couvoisier DS, Genevay S (2019) Glucocorticoid injections for greater trochanteric pain syndrome: a randomized double-blind placebo-controlled (GLUTEAL) trial. Clin Rheumatol 38:647–655CrossRefPubMed Nissen MJ, Brulhart L, Faundez A, Finckh A, Couvoisier DS, Genevay S (2019) Glucocorticoid injections for greater trochanteric pain syndrome: a randomized double-blind placebo-controlled (GLUTEAL) trial. Clin Rheumatol 38:647–655CrossRefPubMed
2.
go back to reference MacMahon PJ, Eustace SJ, Kavanagh EC (2009) Injectable corticosteroid and local anesthetic preparations. Radiology 252:647–661CrossRefPubMed MacMahon PJ, Eustace SJ, Kavanagh EC (2009) Injectable corticosteroid and local anesthetic preparations. Radiology 252:647–661CrossRefPubMed
3.
go back to reference Williams BS, Cohen SF (2009) Greater trochanteric pain syndrome: a review of anatomy, diagnosis and treatment. Anesth Analg 108:1662–1670CrossRefPubMed Williams BS, Cohen SF (2009) Greater trochanteric pain syndrome: a review of anatomy, diagnosis and treatment. Anesth Analg 108:1662–1670CrossRefPubMed
4.
go back to reference Dunn T, Heller CA, McCarthy SW, Dos Remedios C (2003) Anatomical study of the “trochanteric bursae”. Clin Anat 16:233–240CrossRefPubMed Dunn T, Heller CA, McCarthy SW, Dos Remedios C (2003) Anatomical study of the “trochanteric bursae”. Clin Anat 16:233–240CrossRefPubMed
5.
go back to reference Cole BJ, Schumacher HR Jr (2005) Injectable corticosteroids in modern practice. J Am Acad Orthop Surg 13:37–46CrossRefPubMed Cole BJ, Schumacher HR Jr (2005) Injectable corticosteroids in modern practice. J Am Acad Orthop Surg 13:37–46CrossRefPubMed
6.
go back to reference McAlindon T, LaValley M, Harvey W, Price LL, Driban JB, Zhang M, Ward RJ (2017) Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA 317:1967–1975CrossRefPubMedPubMedCentral McAlindon T, LaValley M, Harvey W, Price LL, Driban JB, Zhang M, Ward RJ (2017) Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA 317:1967–1975CrossRefPubMedPubMedCentral
Metadata
Title
Elusive trochanteric bursitis relief
Author
Bruce Rothschild
Publication date
01-06-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 6/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04560-y

Other articles of this Issue 6/2019

Clinical Rheumatology 6/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.